Literature DB >> 7049348

Direct cloning of human breast cancer in soft agar culture.

J Sandbach, D D Von Hoff, G Clark, A B Cruz, M Obrien.   

Abstract

A human tumor cloning system has been utilized to grow human breast carcinoma. A total of 225 specimens have been placed in culture. One hundred thirty-two were from primary chest cancer specimens and 93 were from metastatic lesions. Of these, 71% of the primary breast carcinomas and 75% of metastases formed greater than or equal to 5 colonies per 500,000 cells plated. Forty-five percent of the primary breast carcinomas and 52% of the metastases formed enough colonies (greater than or equal to 30 colonies per 500,000 cells plated) to perform meaningful in vitro drug testing. Estrogen receptor status did not influence the percentage of tumors which formed colonies in vitro. Histologic and nude mouse studies provided confirmatory evidence the colonies were composed of breast cancer cells. In 176 in vitro chemotherapeutic drug tests, the anticancer agents commonly used clinically for treatment of breast cancer, i.e., Adriamycin, 5-fluorouracil, etc., showed some in vitro activity. This activity was not as dramatic as is seen in the clinic with these conventional agents. Future work should concentrate on improving the number of colonies which form from breast cancer specimens and on prospective use of the system for screening for new agents for the treatment of human breast cancer.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7049348     DOI: 10.1002/1097-0142(19821001)50:7<1315::aid-cncr2820500717>3.0.co;2-7

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  14 in total

Review 1.  Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays. II. Assay methods, adriamycin and the other antitumour antibiotics.

Authors:  A G Bosanquet
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

2.  Long-term culture of primary breast cancer in defined medium.

Authors:  H M McCallum; G W Lowther
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

Review 3.  Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays. III. Antimetabolites, tubulin-binding agents, platinum drugs, amsacrine, L-asparaginase, interferons, steroids and other miscellaneous antitumor agents.

Authors:  A G Bosanquet
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

4.  Colony growth of cells from primary breast carcinoma in soft agar culture.

Authors:  T Wada; T Akiyoshi; Y Nakamura; H Tsuji
Journal:  Jpn J Surg       Date:  1984-05

5.  Heterogeneity of in vitro chemosensitivity in perioperative breast cancer cells to mitoxantrone versus doxorubicin evaluated by a microplate ATP bioluminescence assay.

Authors:  C M Kurbacher; I A Cree; U Brenne; H W Bruckner; J A Kurbacher; P Mallmann; P E Andreotti; D Krebs
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

6.  Successful in vitro growth of human head and neck cancer after transplantation in nude mice.

Authors:  E C Heinerman; B J Braakhuis; G H Boerrigter; G B Snow
Journal:  Arch Otorhinolaryngol       Date:  1985

7.  Flow cytometric analysis of human breast tumors and assessment of in vitro chemosensitivity by clonogenic assays.

Authors:  J Huot; J Aubin; F Goulet; R Goyette
Journal:  Cell Biol Toxicol       Date:  1990-01       Impact factor: 6.691

Review 8.  Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays. General considerations, the nitrosoureas and alkylating agents.

Authors:  A G Bosanquet
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

Review 9.  Prediction of response to cancer chemotherapy.

Authors:  M F Sarosdy; D D Von Hoff
Journal:  Drugs       Date:  1983-11       Impact factor: 9.546

10.  In vitro growth and chemosensitivity studies of childhood cancers using clonogenic assay.

Authors:  M Shibata; S Yasumuro; W Ugajin; Y Kurosu; I Okabe; K Morita
Journal:  Jpn J Surg       Date:  1986-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.